PatientsVille.com Logo

AMNESIA and Celexa

PatientsVille

AMNESIA Symptoms and Causes

Every day, you have different experiences and you learn new things. Your brain cannot store all of that information, so it has to decide what is worth remembering. Memory is the process of storing and then remembering this information. There are different types of memory. Short-term memory stores information for a few seconds or minutes. Long-term memory stores it for a longer period of time.

Memory doesn't always work perfectly. As you grow older, it may take longer to remember things.

It's normal to forget things once in awhile. We've all forgotten a name, where we put our keys, or if we locked the front door. If you are a senior who forget things more often than others your age, you may have mild cognitive impairment. Forgetting how to use your phone or find your way home may be signs of a more serious problem, such as

  • Alzheimer's disease
  • Other types of dementia
  • Stroke
  • Depression
  • Head injuries
  • Blood clots or tumors in the brain
  • Kidney, liver, or thyroid problems
  • Reactions to certain medicines

If you're worried about your forgetfulness, see your health care provider.

NIH: National Institute on Aging

Check out the latest treatments for AMNESIA

AMNESIA treatment research studies

Celexa clinical trials, surveys and public health registries


Find Drug Side Effect reports



Celexa Side Effects

Dizziness (136)
Nausea (135)
Anxiety (127)
Suicidal Ideation (124)
Depression (123)
Headache (120)
Completed Suicide (120)
Pain (111)
Insomnia (109)
Feeling Abnormal (102)
Vomiting (101)
Diarrhoea (99)
Fall (96)
Fatigue (91)
Loss Of Consciousness (89)
Tremor (89)
Dyspnoea (85)
Agitation (78)
Confusional State (76)
Aggression (69)
Asthenia (38)
Convulsion (34)
Suicide Attempt (33)
Condition Aggravated (32)
Abnormal Behaviour (32)
Weight Increased (31)
Somnolence (30)
Anger (30)
Pulmonary Embolism (28)
Malaise (28)
Chest Pain (28)
Crying (27)
Irritability (27)
Abdominal Pain Upper (25)
Abdominal Pain (25)
Constipation (25)
Overdose (25)
Serotonin Syndrome (25)
Paraesthesia (25)
Syncope (24)
Amnesia (24)
Hyperhidrosis (24)
Intentional Self-injury (22)
Hypertension (21)
Arthralgia (21)
Injury (20)
Palpitations (20)
Heart Rate Increased (20)
Blood Pressure Increased (20)
Rash (19)

➢ More


Common Meds

Abilify (10132)
Adderall (1304)
Amlodipine (6664)
Amoxicillin (4387)
Benadryl (1568)
Celebrex (12876 )
Celexa (1342)
Cialis (2975)
Cipro (8580)
Citalopram (7792)
Crestor (18839)
Cymbalta (14373)
Doxycycline (1757)
Effexor (7289)
Flexeril (435)
Flomax (2177)
Fluoxetine (4261)
Gabapentin (4593)
Hydrocodone (2469)
Ibuprofen (8222)
Lantus (10968)
Lexapro (3499)
Lipitor (17769)
Lisinopril (8919)
Lyrica (27148)
Medrol (650)
Mirena (41254)
Mobic (957)
Morphine (5356)
Naproxen (538)
Neurontin (6501)
Oxycodone (4438)
Pradaxa (13372)
Prednisone (5926)
Prilosec (2631)
Prozac (1954)
Seroquel (27216)
Simvastatin (8348)
Synthroid (4452)
Tamiflu (5585)
Topamax (3748)
Tramadol (5054)
Trazodone (1458)
Viagra (5394)
Vicodin (1153)
Wellbutrin (6324)
Xanax (2847)
Zocor (5718)
Zoloft(6792)
Zyrtec(1669)

Recent Reviews

Can ratio-citalopram be taken long term with Lectopam 6 mg?

Celexa triggered my tourettes syndrome. Three weeks after starting this med, I started having motor and vocal tics. Do not advise anyone to take this drug. It sucks.

I need to find out if Celexa is available in Ecuador as I will be living there for several months. Thanks.

I Took celexa for about 7 years im a 28 year old male. A couple months after getting off of the drug I have been twitching all over my body. Feet, legs,thighs,arms,stomach,hands,face,everywhere. I also have this feeling of a lump stuck in my throat.

It probably didn't trigger your TS. It was probably just supressing symptoms to a point where they were un noticable. Celexa is something they use to help alleviate the symptoms. so when you came off of it, they came back. They could have developed w

After several small sips of Benylin DM-E ( regular strength), an episode of transient global amnesia. Same had occurred many years earlier after absorbing a number of throat lozenges on an airplane

Agressividade, irritabilidade, alteraao de comportamento, refluxo, amnesia, arrogancia

Amnesia, found out the next morning I had sent numerous E-mails & sent text messages& held conversation I was unaware of any of it.

DEAR SIRS I got VALDOXAN for about a month and the result so far is to getting Depression-Amnesia-heavy Thought-Shaking MORE STRESS-Dizzy MIND ETC PLEASE YOUR OPINION

Has anyone experienced amnesia or a black out episode from Lexapro? I experienced such an episode and would like to discuss with anyone who has had the same.

I had from the hospital and got as prescription from the hospital for my serious migraine. The headache was even worse. I had all kinds of side effects such as sleep walking, amnesia, and fall. I would not like to take the endone no more.

I went for an MRI with contrast. When the gadalinium was administered, I experienced a transient global amnesia event. I had to be taken to an ER and was admitted to the hospital. Docs insisted the gadalinium would not t

Incurred skull fracture that req'd a NeuroSurgeon in 1971 (15 yrs old)- coma, amnesia, anticonvulsant meds - learned how to walk/talk & remember who people were quite quickly. Was diagnosed with deep depression at age 25 (

Thanks for your comments Jacqueline. My dad was put on Exelon a couple of months ago. We were devastated when he started wandering around at midnight and didn't know who we were - amnesia, severe confusion - call it what you like. We had hoped this d

AMNESIA Clinical Trials and Studies

Treatments might be new drugs or new combinations of drugs, new surgical procedures or devices, or new ways to use existing treatments. The goal of clinical trials is to determine if a new test or treatment works and is safe. Clinical trials can also look at other aspects of care, such as improving the quality of life for people with chronic illnesses. People participate in clinical trials for a variety of reasons. Healthy volunteers say they participate to help others and to contribute to moving science forward. Participants with an illness or disease also participate to help others, but also to possibly receive the newest treatment and to have the additional care and attention from the clinical trial staff.
Rank Status Study
1 Not yet recruiting Transient Global AMNESIA (TGA). Exploratory Study of the Default Mode Network During the Acute Phase
Condition: AMNESIA
Intervention: Other: IRMf
Outcome Measures: The primary judgment criteria will be the difference in activation probabilistic resting state maps between patient and control groups during the acute phase.;   memory performance tests and functional activity
2 Recruiting Screening for Memory Studies
Conditions: Memory Loss;   Memory Deficits;   Dementia
Intervention: Behavioral: Memtrax Memory screening test
Outcome Measure:
3 Recruiting Phytoserms for Menopause Symptoms and Age-Associated Memory Decline
Conditions: Hot Flashes;   Memory Loss
Interventions: Dietary Supplement: PhytoSERM tablet;   Dietary Supplement: placebo
Outcome Measures: safety and tolerability;   efficacy
4 Not yet recruiting Measurement of Retinal Nerve Fiber Layer Thickness - a Biomarker for the Early Detection of Alzheimer's Disease?
Condition: Alzheimer's Disease
Intervention:
Outcome Measures: Measurement of retinal nerve fiber layer thickness;   Cognitive function
5 Recruiting A Study Comparing Long-acting Methylphenidate (ConcertaTM) vs. Placebo in the Treatment of Memory Loss Due to HIV
Condition: HIV Dementia
Interventions: Drug: Long acting methylphenidate;   Drug: Matched placebo
Outcome Measures: Change in rate of reaction time as measured by neuropsychological testing;   Number of Subjects with Adverse Events as Measures of Safety and Tolerability of Concerta in HIV infected adults
6 Recruiting Effects of Aging and Estrogen on Memory and Cognition
Conditions: Memory Loss;   Cognitive Changes;   Postmenopausal Symptoms
Intervention: Drug: Estradiol
Outcome Measures: Neuroimaging changes in response to estrogen;   Neuropsychological testing changes in response to receiving estradiol
7 Recruiting Study Comparing Magnetic Seizure Therapy (MST) to Electroconvulsive Therapy (ECT) for Depression in Older Adults
Conditions: Depression;   Major Depressive Episode;   Bipolar Disorder
Interventions: Device: MagVenture MagPro MST;   Device: RUL ECT
Outcome Measures: Clinical improvement (Hamilton Rating Scale for Depression);   Clinical improvement (Inventory of Depressive Symptomatology - Clinician-Rated)
8 Recruiting Screening and Evaluation of Patients With Signs and Symptoms of Alzheimer's Disease
Condition: Alzheimer's Disease
Intervention:
Outcome Measure:
9 Recruiting Effect of Midazolam Premedication Before Induction on the Functional Recovery After General Anesthesia in the Patients Undergoing Breast Surgery Due to Breast Cancer
Condition: Breast Cancer
Intervention: Drug: midazolam premedication
Outcome Measure: The QoR-40 administered 24 hours after the operation is the primary endpoint of this research.
10 Recruiting Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss
Condition: Cognition Disorders
Interventions: Drug: Solanezumab;   Drug: Placebo
Outcome Measures: Change from Baseline of the ADCS Preclinical Alzheimer Cognitive Composite (ADCS-PACC) to Week 168;   Change from Baseline in Cognitive Function Index (CFI) to Week 156;   Change from Baseline in Alzheimer's Disease Cooperative Study—Activities Daily Living—Prevention Instrument (ADCS-ADL-PI) Score to Week 156;   Change from Baseline in Mean Composite Summary Uptake Value Ratio (SUVr) to Week 168;   Change from Baseline in Cerebral Spinal Fluid (CSF) Tau Biomarkers to Week 168;   Change from Baseline of Cerebrospinal Fluid (CSF) Concentrations of Amyloid Beta (Abeta) to Week 168;   Change from Baseline of Volumetric Magnetic Resonance Imaging (vMRI) to Week 168
11 Recruiting Skull Base and Low Grade Glioma Neurocognitive Magnetic Resonance Imaging (MRI) Study
Conditions: Malignancy;   Glioma;   Radiotherapy
Interventions: Radiation: Photon treatment plans;   Radiation: Proton Treatment Plans;   Behavioral: Neurocognitive evaluation;   Device: Advanced MRI imaging
Outcome Measures: Neurocognitive evaluation;   Advance MRI imaging
12 Recruiting Effect of Insulin Sensitizer Metformin on AD Biomarkers
Conditions: Alzheimer's Disease;   Vascular Dementia;   Dementia;   Memory Impairment
Intervention: Drug: Metformin
Outcome Measures: Cognitive Biomarker Outcomes;   Neurophysiological Biomarker Outcome
13 Recruiting Sleep Apnea in Early to Mid-Stage Alzheimer's Disease
Conditions: Early Onset Alzheimer Disease;   Alzheimer Disease;   Obstructive Sleep Apnea Syndromes
Interventions: Device: CPAP Treatment;   Device: No treatment
Outcome Measures: Impact of the CPAP treatment on cognitive functions;   Rate of apnea/hypopnea events per hour (AHI/h);   Impact of CPAP treatment on neuropsychological evaluation parameters;   Impact of the CPAP treatment on Quality of Life
14 Not yet recruiting Evaluation Prospectively the Level of Reduction in Cognitive Functions of Cancer Patients Who Are on Active Oncology Treatments and Use Cannabis. The Second Goal is to Identify High-risk Groups for Cognitive Impairment Due to Cannabis Use.
Conditions: 1- Cancer Patients During Chemotherapy Treatment;   2- Use of Cannabis Comparing to Control Without Cannabis Use
Intervention: Drug: cannabis
Outcome Measure: Cannabis effect on cognitive function during chemotherapy
15 Recruiting Liver Fibrosis in Alpha-1 Antitrypsin Deficiency (AATD)
Conditions: Liver Fibrosis;   Alpha-1 Antitrypsin Deficiency;   AAT Deficiency;   AATD
Interventions: Device: Abdominal ultrasound;   Procedure: History and physical;   Procedure: Intravenous catheter;   Procedure: Blood draw;   Other: Liver questionnaire;   Procedure: Liver Biopsy;   Drug: Midazolam;   Drug: Fentanyl;   Drug: Lidocaine;   Drug: Acetaminophen;   Drug: Lorazepam;   Drug: Oxycodone/Acetaminophen;   Drug: Ondansetron
Outcome Measures: To estimate the prevalence and histologic spectrum of liver injury in an adult with Alpha-1 Antitrypsin deficiency and a genotype of ZZ.;   To identify environmental and host risk factors for clinically significant liver fibrosis.;   To define the diagnostic accuracy of non-invasive markers of fibrosis in AAT liver disease.;   To explore epigenetic markers for the development of liver fibrosis.;   To quantify liver fibrosis progression.
16 Unknown  Propofol Sedation During Upper Endoscopy With and Without Topical Pharyngeal Anesthesia
Condition: Conscious Sedation
Interventions: Drug: Lidocaine 10%;   Drug: Diluted gentian root solution
Outcome Measures: Number triggered gag reflex during the intubation of the endoscope;   Number of attempts of intubation with the endoscope through the upper esophageal sphincter;   Extent of salivation during intubation;   Amount of propofol used to successfully intubate the esophagus;   Total amount of propofol used during the investigation;   Overall assessment of the procedure by the endoscopist;   Assumption of the endoscopist if lidocaine or placebo has been used;   Overall assessment of the investigation by the patient;   Extent of AMNESIA in the patient;   Experienced problems (aspiration, bronchospasm, desaturation);   The impact of the individual endoscopists or registered nurses involved in the endoscopy
17 Recruiting Efficacy of Propofol or Midazolam Compare to Placebo for Preoperative Medication
Condition: Elective Orthopedic Surgery
Interventions: Drug: Midazolam;   Drug: Propofol;   Drug: Saline
Outcome Measures: reduces anxiety;   reduces sleepiness;   produces AMNESIA(temporary lack of recall);   Satisfaction
18 Recruiting Sedation During Bronchoscopy:Dexmedetomidine vs Alfentanil
Conditions: Bronchoscopy;   Conscious Sedation
Interventions: Drug: xylocain;   Drug: Alfentanil;   Drug: Dexmedetomidine
Outcome Measures: Bronchoscopy score;   Level of sedation for bronchoscopy
19 Recruiting Randomized Clinical Trial of Propofol, 1:1 and 4:1 Combination of Propofol and Ketamine for Procedural Sedation
Condition: Procedural Sedation
Interventions: Drug: Propofol;   Drug: 1:1 Propofol/Ketamine;   Drug: 4:1 Propofol/Ketamine
Outcome Measures: Clinical interventions during sedation;   Hypoxia;   Respiratory depression;   Procedural pain and recall
20 Unknown  Explore the Nature Factors Relevant to Learning-Pioneering Natural Factors That Influences Science Learning II
Condition: Healthy
Intervention:
Outcome Measure: observational studies, related to core objectives of the study and learning.